Nicotine replacement therapy [7 mg, 14mg, and 21 mg patch] for use as aid to decrease withdrawal symptoms triggered by tobacco cessation (smoking and smokeless tobacco products)
Pre-Cycle 1 | DrugsHTA Council Recommendation (as of 17 May 2021)
As final recommendation, the HTA Council recommends the inclusion of Nicotine replacement therapy [7 mg, 14mg, and 21 mg patch] for use as aid to decrease withdrawal symptoms triggered by tobacco cessation (smoking and smokeless tobacco products) in the Philippine National Formulary (PNF).
Relevant Information
- Status: With Final HTA Council Recommendation and SOH Decision
- Topic Assignment: Internal Assessment
- Secretary of Health Decision: Approved as of 20 May 2021
Evidence and Relevant Documents